BIOLEXA led to significant improvement in disease severity as measured by SCORAD and EASI Using the EASI scale, 100% of patients showed clinically relevant improvement >50% compared to Day 1 during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback